Notably, high mRNA expression of FAM3C was found to be independently associated with significantly shorter overall survival in glioma patients, even after accounting for clinical variables such as World Health Organization classification, tumor type, chemotherapy, and 1p19q status (Table 2). This evidence concerns the gene FAM3C and neoplasm.